Farmak, A.S.
Records under this name other than the patents Farmak, A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Farmak, A.S.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,487,113 | Method for the preparation of tizanidine hydrochloride Lapsed on the fee record Ended Jul 16, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2025 | From the USPTO record |
| US 8,129,421 | Method for preparing 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]-benzoic acid Lapsed on the fee record Ended Mar 6, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 6, 2024 | From the USPTO record |
| US 10,450,267 | Method for preparing N-[4-(2-{[2-(4-methane sulfonamidophenoxy) ethyl] (methyl)amino}ethyl)phenyl]methanesulfonamide (dofetilide) Lapsed on the fee record Ended Oct 22, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 22, 2023 | From the USPTO record |
| US 8,933,250 | Process for the preparation of N-(1-benzo[b]thien-2-ylethyl)-N-hydroxyurea Lapsed on the fee record Ended Jan 13, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jan 13, 2023 | From the USPTO record |
| US 8,034,805 | Methods for the preparation of salts of 2-[2-(4-dibenzo[B,F][1,4]thiazepin-11-yl-1-piperazinyl)ethoxyl]ethanol (quetiapine) and for the purification thereof Lapsed on the fee record Ended Oct 11, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 11, 2015 | From the USPTO record |
| US H002,154 | Process for preparing R- and S-isomers of (R)-5-(2-( (2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide no-term | no-term |